JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$1.18B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.07B |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 5 |
Medtronic
MDT
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.5B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$716M |
| 4 |
Chubb
CB
|
+$675M |
| 5 |
Lowe's Companies
LOW
|
+$661M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.13% |
| 2 | Financials | 15.03% |
| 3 | Technology | 12.86% |
| 4 | Healthcare | 9.44% |
| 5 | Consumer Discretionary | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3601
CALL
Blackrock
BLK
$165B
| $813K | ﹤0.01% |
+1,500
| New | +$823K |
2018 Q1
0 quarters
|
|
|
3602
PUT
Blackrock
BLK
$165B
| $813K | ﹤0.01% |
1,500
-5,000
| -77% | -$2.74M |
2016 Q4
5 quarters
|
|
3603
VanEck India Growth Leaders ETF
GLIN
$86.9M
| $813K | ﹤0.01% |
14,210
-117,842
| -89% | -$7.53M |
2017 Q2
3 quarters
|
|
3604
MacroGenics
MGNX
$229M
| $812K | ﹤0.01% |
32,262
+6,178
| +24% | +$150K |
2013 Q4
17 quarters
|
|
3605
iShares US Basic Materials ETF
IYM
$1.11B
| $811K | ﹤0.01% |
8,440
+8,340
| +8,340% | +$855K |
2016 Q2
7 quarters
|
|
3606
Viavi Solutions
VIAV
$11B
| $811K | ﹤0.01% |
83,523
-190,234
| -69% | -$1.81M |
2013 Q2
19 quarters
|
|
3607
Cytokinetics
CYTK
$9.12B
| $809K | ﹤0.01% |
112,399
+25,014
| +29% | +$214K |
2017 Q4
1 quarter
|
|
3608
Weyco Group
WEYS
$480M
| $807K | ﹤0.01% |
24,020
-2,314
| -9% | -$73.1K |
2017 Q4
1 quarter
|
|
3609
State Street SPDR S&P Health Care Equipment ETF
XHE
$190M
| $805K | ﹤0.01% |
11,545
-48,068
| -81% | -$3.27M |
2017 Q2
3 quarters
|
|
|
NTRI
3610
DELISTED
NutriSystem, Inc.
NTRI
| $803K | ﹤0.01% |
29,763
+311
| +1% | +$12.4K |
2014 Q4
13 quarters
|
|
3611
Icahn Enterprises
IEP
$4.81B
| $802K | ﹤0.01% |
14,064
+570
| +4% | +$32.5K |
2015 Q1
12 quarters
|
|
3612
Caesarstone
CSTE
$96.1M
| $800K | ﹤0.01% |
40,694
-7,045
| -15% | -$152K |
2013 Q2
19 quarters
|
|
3613
InterContinental Hotels
IHG
$23.6B
| $798K | ﹤0.01% |
12,382
-2,963
| -19% | -$201K |
2013 Q2
19 quarters
|
|
3614
Tennant Co
TNC
$1.14B
| $795K | ﹤0.01% |
11,738
-7,291
| -38% | -$495K |
2013 Q2
19 quarters
|
|
3615
Zevra Therapeutics
ZVRA
$605M
| $795K | ﹤0.01% |
6,290
+6,251
| +16,028% | +$604K |
2017 Q3
2 quarters
|
|
|
ANAT
3616
DELISTED
American National Group, Inc. Common Stock
ANAT
| $795K | ﹤0.01% |
6,795
-328
| -5% | -$39.7K |
2015 Q2
11 quarters
|
|
|
SRDX
3617
DELISTED
Surmodics
SRDX
| $794K | ﹤0.01% |
20,864
-9,439
| -31% | -$292K |
2013 Q2
19 quarters
|
|
3618
PUT
Opko Health
OPK
$1.17B
| $793K | ﹤0.01% |
250,000
-115,000
| -32% | -$463K |
2017 Q3
2 quarters
|
|
3619
PUT
Williams-Sonoma
WSM
$27.5B
| $791K | ﹤0.01% |
30,000
+5,200
| +21% | +$137K |
2017 Q2
3 quarters
|
|
3620
Installed Building Products
IBP
$5.12B
| $790K | ﹤0.01% |
13,142
-32,683
| -71% | -$2.17M |
2017 Q1
4 quarters
|
|
|
NXGN
3621
CALL
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $789K | ﹤0.01% |
+57,800
| New | +$762K |
2018 Q1
0 quarters
|
|
3622
Liberty Media Corporation Series C Common Stock
FWONK
$23B
| $787K | ﹤0.01% |
26,437
-1,830
| -6% | -$60.5K |
2014 Q3
14 quarters
|
|
3623
Gladstone Capital
GLAD
$439M
| $785K | ﹤0.01% |
45,596
+3,396
| +8% | +$61.1K |
2015 Q4
9 quarters
|
|
3624
iShares US Consumer Staples ETF
IYK
$1.37B
| $784K | ﹤0.01% |
19,770
-171
| -0.9% | -$7.07K |
2017 Q4
1 quarter
|
|
3625
First Trust Water ETF
FIW
$1.72B
| $783K | ﹤0.01% |
16,400
| – | – |
2017 Q3
2 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2018 Portfolio in Review
As of Q1 2018, JP Morgan Chase held 5,855 positions worth $467B, down 1.7% from $475B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2018 filing shows 386 new, 1,953 increased, 2,569 reduced and 469 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M. The largest sale was Apple, an estimated $1.5B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, up from 22% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M.
- JP Morgan Chase added most to iShares MSCI Japan ETF in Q1 2018, an estimated $1.18B increase.
- JP Morgan Chase's biggest Q1 2018 reduction was Apple, cutting an estimated $1.5B.
- JP Morgan Chase fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $168M.
- JP Morgan Chase's ten largest holdings make up 18% of its $467B portfolio in Q1 2018.
- JP Morgan Chase opened 386 new positions and closed 469 in Q1 2018.
- JP Morgan Chase's portfolio value fell 1.7% quarter-over-quarter to $467B.
Based on JP Morgan Chase's 13F filing for Q1 2018, filed 10 May 2018.